Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study
PHASE2CompletedINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
September 30, 2002
Study Completion Date
December 31, 2002
Conditions
Critically Ill Patients
Interventions
DRUG
to implement an insulin protocol with target blood glucose levels between 81-110 mg/dL.
Trial Locations (1)
9000
University Hospital Ghent, Ghent
All Listed Sponsors
lead
University Hospital, Ghent
OTHER
NCT00288743 - Adherence, Efficacy and Safety of an Insulin Protocol in the Critically Ill: A Prospective Observational Study | Biotech Hunter | Biotech Hunter